2,292 Shares in MKS Inc. $MKSI Bought by Kera Capital Partners Inc.

Kera Capital Partners Inc. acquired a new stake in shares of MKS Inc. (NASDAQ:MKSI) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 2,292 shares of the scientific and technical instruments company’s stock, valued at approximately $366,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in shares of MKS by 3.6% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 267,421 shares of the scientific and technical instruments company’s stock valued at $21,434,000 after buying an additional 9,170 shares in the last quarter. EverSource Wealth Advisors LLC raised its stake in shares of MKS by 63.4% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 838 shares of the scientific and technical instruments company’s stock worth $83,000 after acquiring an additional 325 shares in the last quarter. First Trust Advisors LP raised its stake in shares of MKS by 3,545.6% during the 2nd quarter. First Trust Advisors LP now owns 141,267 shares of the scientific and technical instruments company’s stock worth $14,036,000 after acquiring an additional 137,392 shares in the last quarter. Cerity Partners LLC purchased a new stake in MKS during the second quarter valued at approximately $1,676,000. Finally, AXA S.A. boosted its stake in MKS by 22.8% in the second quarter. AXA S.A. now owns 29,253 shares of the scientific and technical instruments company’s stock valued at $2,907,000 after acquiring an additional 5,430 shares in the last quarter. Hedge funds and other institutional investors own 99.79% of the company’s stock.

MKS Stock Performance

Shares of MKS stock opened at $406.37 on Monday. The firm’s 50 day simple moving average is $310.09 and its two-hundred day simple moving average is $245.85. The firm has a market capitalization of $27.45 billion, a price-to-earnings ratio of 85.01, a PEG ratio of 1.45 and a beta of 1.99. MKS Inc. has a 12-month low of $88.49 and a 12-month high of $408.87. The company has a current ratio of 1.11, a quick ratio of 0.70 and a debt-to-equity ratio of 0.94.

MKS (NASDAQ:MKSI) last posted its quarterly earnings data on Wednesday, May 6th. The scientific and technical instruments company reported $2.30 EPS for the quarter, topping the consensus estimate of $2.00 by $0.30. The business had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $1.05 billion. MKS had a net margin of 8.06% and a return on equity of 21.49%. The business’s revenue for the quarter was up 15.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.71 earnings per share. MKS has set its Q2 2026 guidance at 2.600-3.200 EPS. Analysts predict that MKS Inc. will post 11.73 EPS for the current year.

MKS Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, June 12th. Shareholders of record on Wednesday, June 3rd were paid a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 0.2%. The ex-dividend date was Wednesday, June 3rd. MKS’s payout ratio is presently 20.92%.

Insiders Place Their Bets

In related news, EVP David Philip Henry sold 2,500 shares of the stock in a transaction that occurred on Tuesday, May 26th. The shares were sold at an average price of $330.50, for a total value of $826,250.00. Following the transaction, the executive vice president owned 16,341 shares in the company, valued at approximately $5,400,700.50. This represents a 13.27% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Kathleen Flaherty Burke sold 4,355 shares of the firm’s stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $319.94, for a total transaction of $1,393,338.70. Following the transaction, the executive vice president directly owned 49,439 shares of the company’s stock, valued at $15,817,513.66. This represents a 8.10% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 53,949 shares of company stock valued at $17,446,108. Insiders own 0.57% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have issued reports on MKSI. The Goldman Sachs Group reaffirmed a “sell” rating and issued a $265.00 price target on shares of MKS in a report on Thursday, May 7th. Mizuho set a $400.00 price objective on MKS in a research report on Wednesday, May 27th. Weiss Ratings reissued a “hold (c)” rating on shares of MKS in a research report on Tuesday, April 21st. TD Cowen restated a “buy” rating on shares of MKS in a research note on Thursday, May 7th. Finally, Citigroup upped their target price on MKS from $290.00 to $355.00 and gave the company a “buy” rating in a research report on Friday, May 8th. Two research analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $324.92.

MKS Profile

MKS Instruments, Inc (NASDAQ: MKSI) designs, manufactures and markets technology solutions that enable advanced processes in a variety of high‐technology and industrial markets. The company’s core offerings include vacuum and gas delivery systems, pressure and flow measurement instruments, optical metrology tools, photonics subsystems and critical components for manufacturing processes. These products support the precise control and monitoring needs of semiconductor, industrial manufacturing, life and health sciences, and research applications.

The company’s product portfolio features mass flow controllers, pressure transducers, vacuum gauges, gas purity monitors, laser-based metrology systems and photonic devices such as lasers and detectors.